跳至主要内容
临床试验/NCT01971021
NCT01971021已完成不适用

Vascular Access in Cancer Patients - PICC vs PORT in a Randomized Controlled Trial.

Linkoeping University2 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2013年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
400
试验地点
2
主要终点
The occurence of catheter related venous thrombosis

研究概览

简要总结

As of today there is very limited scientific knowledge in whicj of the two vascular access devices (PICC-line or venous ports) that offers the lowest complicationrates in cancerpatients. The study group wants to clearify this unsolved matter by comparing the two systems. Our primary endpoint is the presens of catheter related venous thrombosis. We are also looking at all catheter related complications and patient satisfaction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • cancer treatment with need for central venous access
  • Age >18 yrs
  • Suspected survival > 4 weeks
  • Need of central venous access >4 weeks

排除标准

  • Ongoing uncontrolled systemic infection
  • Prescence of significant thrombosis/stenosis in arm or central veins
  • Unability to communicate
  • Probable upcoming need for dialysis fistula

研究组 & 干预措施

PICC-line

Active Comparator

PICC line insertion.

干预措施: PICC or subcutaneous venous port (Device)

PORT

Active Comparator

Subcutaneous venous port insertion

干预措施: PICC or subcutaneous venous port (Device)

结局指标

主要结局

The occurence of catheter related venous thrombosis

时间窗: Upon clinical suspiscion during the one the patient i enrolled in the study

regular follow-ups at month 1, 3, 6 and 12.

次要结局

未报告次要终点

研究者

发起方
Linkoeping University
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Knut Taxbro

MD Consultant in Anesthesia and Intensive Care

Linkoeping University

研究点 (2)

Loading locations...

相似试验